Clinical trial
Limiting HIV Target Cells by Inducing Immune Quiescence in the Female Genital Tract
NCT02079077 is registered in ClinicalTrials.gov with University of Manitoba as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Limiting HIV Target Cells by Inducing Immune Quiescence in the Female Genital Tract
- Lead sponsor
- University of Manitoba
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- April 30, 2014
- Completion date
- January 1, 2018
- Enrollment
- 91 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
hiv